openPR Logo

Press Releases from DelveInsight Business Research (5777 total)

Ocular Hypertension Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Ther …

(Las Vegas, Nevada, United States) "Ocular Hypertension Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects

Vasculitis Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Me …

(Albany, USA) DelveInsight's 'Vasculitis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Vasculitis therapies in various stages of clinical development,

Crohn's Disease Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapie …

(Albany, United States) As per DelveInsight's assessment, globally, Crohn's Disease pipeline constitutes 70+ key companies continuously working towards developing 75+ Crohn's Disease treatment therapies, analysis

Breast Cancer Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, …

(Albany, United States) As per DelveInsight's assessment, globally, Breast Cancer pipeline constitutes 120+ key companies continuously working towards developing 130+ Breast Cancer treatment therapies, analysis

Acute Myeloid Leukemia Pipeline Analysis 2024: FDA Approvals, Clinical Trials, T …

(Albany, United States) As per DelveInsight's assessment, globally, Acute Myeloid Leukemia pipeline constitutes 150+ key companies continuously working towards developing 150+ Acute Myeloid Leukemia treatment

Ovarian Cancer Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies …

(Albany, United States) As per DelveInsight's assessment, globally, Ovarian Cancer pipeline constitutes 180+ key companies continuously working towards developing 200+ Ovarian Cancer treatment therapies, analysis

Interstitial Lung Disease Pipeline Analysis 2024: FDA Approvals, Clinical Trials …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Interstitial Lung Disease pipeline constitutes 120+ key companies continuously working towards developing 120+ Interstitial Lung

Type 1 Diabetes Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapie …

(Albany, United States) As per DelveInsight's assessment, globally, Type 1 Diabetes pipeline constitutes 80+ key companies continuously working towards developing 100+ Type 1 Diabetes treatment

Atopic Dermatitis Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therap …

(Albany, USA) "Atopic Dermatitis Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Atopic

Fabry Disease Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, …

(Albany, United States) As per DelveInsight's assessment, globally, Fabry Disease pipeline constitutes 18+ key companies continuously working towards developing 18+ Fabry Disease treatment therapies, analysis

Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) Pipeline Analy …

(Albany, United States) "Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and

FAK Inhibitor Market Forecast 2032 by DelveInsight | Highlighting Key Players in …

(New York, USA) DelveInsight's FAK Inhibitors Competitive Landscape report delivers an in-depth understanding of the FAK inhibitors and the FAK inhibitors market trends in the

The Market share for ULTOMIRIS by Alexion Pharmaceuticals Set to Experience Trem …

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on ULTOMIRIS (Alexion Pharmaceuticals) providing insights into

SOLIRIS by AstraZeneca expected to drive market size of Generalized Myasthenia G …

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on SOLIRIS (AstraZeneca) providing insights into the

Iptacopan A Comprehensive Forecast on the Accelerating Market Growth for Atypica …

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Iptacopan (Novartis) providing insights into the

Crovalimab Poised for Remarkable Market Expansion of Paroxysmal Nocturnal Hemogl …

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Crovalimab (F. Hoffmann-La Roche) providing insights

SOM Biotech's "SOM3355 market size expected to increase many folds by 2032, repo …

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on SOM3355 (SOM Biotech) providing insights into

Diabetic Retinopathy Market Analysis 2032: Epidemiology, Clinical trial, FDA App …

(Albany, USA) DelveInsight's "Diabetic Retinopathy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Diabetic Retinopathy, historical and forecasted epidemiology as well

Opioid Kappa Receptor Agonists Market to Witness Significant Growth by 2034, Ass …

The Opioid Kappa Receptor Agonists market size is anticipated to grow in the upcoming years, largely driven by heightened R&D endeavors across the 7MM. Furthermore,

OX40 Ligand Inhibitors Market to Witness Significant Growth by 2032, Assesses De …

The OX40 Ligand Inhibitors market size is anticipated to grow in the upcoming years, largely driven by heightened R&D endeavors across the 7MM. Furthermore, the

Sphingosine 1 Phosphate Receptor (S1PR) Modulators Market to Witness Significant …

The Sphingosine 1 Phosphate Receptor (S1PR) Modulators market size is anticipated to grow in the upcoming years, largely driven by heightened R&D endeavors across the

Glucose-Dependent Insulinotropic Polypeptide (GIP) Agonist Market to Witness Gro …

The Glucose-dependent Insulinotropic Polypeptide (GIP) Agonist market size is anticipated to grow in the upcoming years, largely driven by heightened R&D endeavors across the 7MM.

The Market share for SAGE-718 by Sage Therapeutics Set to Experience Tremendous …

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on SAGE-718 (Sage Therapeutics) providing insights into

Pridopidine by Prilenia Therapeutics Development expected to drive market size o …

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Pridopidine (Prilenia Therapeutics Development) providing insights

INGREZZA A Comprehensive Forecast on the Accelerating Market Growth for [Indicat …

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on INGREZZA (Neurocrine Biosciences, Inc.) providing insights

ANX005 Poised for Remarkable Market Expansion of Huntington's Disease by 2032

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on ANX005 (Annexon) providing insights into the

UniQure's "AMT-130 market size expected to increase many folds by 2032, report D …

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on AMT-130 (UniQure's) providing insights into the

Glucagon-Like Peptide-1 (Glp-1) Agonists Market to Witness Significant Growth du …

The Glucagon-like Peptide-1 (GLP-1) Agonists market size is anticipated to grow in the upcoming years, largely driven by heightened R&D endeavors across the 7MM. Furthermore,

Phosphodiesterase-4 (PDE4) Inhibitor Market: Anticipated Surge in Growth Through …

(Albany, USA) The Phosphodiesterase-4 (PDE4) Inhibitor market size is anticipated to increase in the study period due to a direct consequence of an increase in

Janus kinase (JAK) Inhibitor Market Poised for Remarkable Growth from 2020 to 20 …

The Janus kinase (JAK) Inhibitor market size is anticipated to increase in the study period due to a direct consequence of an increase in R&D

LY3484356 (Imlunestrant) A Comprehensive Forecast on the Accelerating Market Gro …

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on LY3484356 (Imlunestrant) (Eli Lilly and Company|Loxo Oncology,

LYNPARZA Poised for Remarkable Market Expansion of Pancreatic Cancer by 2032

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on LYNPARZA (AstraZeneca and Merck) providing insights

Pneumococcal Pneumonia Pipeline Assessment 2024 | Clinical Trials, Therapies, La …

(Albany, USA) As per DelveInsight's assessment, globally, about 12+ key pharma and biotech companies are working on 15+ pipeline drugs in the Pneumococcal Pneumonia therapeutics

Sepsis Pipeline Assessment 2024 | Clinical Trials, Therapies, Latest FDA Approva …

(Albany, USA) As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 35+ pipeline drugs in the Sepsis therapeutics landscape

GM2 Gangliosidosis Pipeline Assessment 2024 | Clinical Trials, Therapies, Latest …

(Albany, USA) "GM2 Gangliosidosis Pipeline Insight, 2024" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the

EGFR-Positive Non-Small Cell Lung Cancer (EGFR+ NSCLC) Pipeline Analysis 2024: C …

(Albany, USA) As per DelveInsight's assessment, globally, about 40+ key pharma and biotech companies are working on 42+ pipeline drugs in the EGFR-Positive Non-Small Cell

Retinitis Pigmentosa Pipeline Analysis 2024: Clinical Trials, Therapies, Compani …

(Albany, USA) As per DelveInsight's assessment, globally, about 25+ key pharma and biotech companies are working on 30+ Retinitis Pigmentosa pipeline drugs in the therapeutics

Teva Neuroscience "Austedo" Market size expansion of Several Folds by 2032

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Austedo (Teva Neuroscience) providing insights into

Waylivra A Comprehensive Forecast on the Accelerating Market Growth for Severe H …

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Waylivra (Akcea Therapeutics) providing insights into

XELJANZ Poised for Remarkable Market Expansion of Ulcerative Colitis by 2032

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on XELJANZ (Pfizer) providing insights into the

Janssen Pharmaceuticals "STELARA (Ustekinumab) market size expected to increase …

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on STELARA (Ustekinumab) (Janssen Pharmaceuticals) providing insights

Janssen Biotech, Inc. "Simponi" Market size expansion of Several Folds by 2032

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Simponi (Janssen Biotech, Inc.) providing insights

Asthma Pipeline Analysis 2024: Clinical Trials, Approvals by FDA, EMA, and PMDA, …

(Albany, USA) DelveInsight's 'Asthma Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline asthma therapies in various stages of clinical development,

Projected Expansion of Overactive Bladder Market by 2032, Analysis by DelveInsig …

(New York, USA) DelveInsight's Overactive Bladder Market Insights report includes a comprehensive understanding of current treatment practices, overactive bladder emerging drugs, market share of individual

Projected Growth of Osteoarthritis Market by 2032: Insights from DelveInsight | …

(Albany, USA) DelveInsight's "Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Osteoarthritis, historical and forecasted epidemiology as well as the

Ocular Hypertension Pipeline Analysis 2024: Clinical Trials, FDA Approvals, Ther …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Ocular Hypertension pipeline constitutes 70+ key companies continuously working towards developing 75+ Ocular Hypertension treatment

NK Cell Therapy Pipeline Insight 2024: Clinical Trials, FDA Approvals, Companies …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, NK Cell Therapy pipeline constitutes 100+ key companies continuously working towards developing 185+ NK

Bartonellosis Market Analysis 2032: Epidemiology, Market Size, Share, Treatment …

(New York, USA) DelveInsight's "Bartonellosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Bartonellosis, historical and forecasted epidemiology as well as

Atypical Hemolytic Uremic Syndrome Market Forecasted to Expand by 2032, Projecte …

(Albany, USA) DelveInsight's "Atypical Hemolytic Uremic Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Atypical Hemolytic Uremic Syndrome, historical and

Hyperhidrosis Market Forecast 2032: Epidemiological Insights, Market Dynamics, T …

(New York, USA) DelveInsight's "Hyperhidrosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hyperhidrosis, historical and forecasted epidemiology as well as

Go To Page:    51 52 53 54 55 56 57 58 59 60